Cargando…
COVID‐19 infection in primary central nervous system lymphoma treatment: Who is most at risk?
Autor principal: | Lim, Sean H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538935/ https://www.ncbi.nlm.nih.gov/pubmed/36017936 http://dx.doi.org/10.1111/bjh.18416 |
Ejemplares similares
-
Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016) -
Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015) -
Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018) -
Primary Angiitis of the Central Nervous System: A Terra Incognita
por: Verma, Rajesh, et al.
Publicado: (2022) -
Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)